Family therapy for autism spectrum disorders. by Spain, D. et al.
              
City, University of London Institutional Repository
Citation: Spain, D., Sin, J. ORCID: 0000-0003-0590-7165, Paliokosta, E., Furuta, M., 
Prunty, J. E., Chalder, T., Murphy, D. G. and Happé, F. G. (2017). Family therapy for autism 
spectrum disorders.. Cochrane Database of Systematic Reviews, 5, doi: 
10.1002/14651858.CD011894.pub2 
This is the published version of the paper. 
This version of the publication may differ from the final published 
version. 
Permanent repository link:  https://openaccess.city.ac.uk/id/eprint/24537/
Link to published version: http://dx.doi.org/10.1002/14651858.CD011894.pub2
Copyright and reuse: City Research Online aims to make research 
outputs of City, University of London available to a wider audience. 
Copyright and Moral Rights remain with the author(s) and/or copyright 
holders. URLs from City Research Online may be freely distributed and 
linked to.
City Research Online:            http://openaccess.city.ac.uk/            publications@city.ac.uk
City Research Online
 Explore new Cochrane Library features here. 
Cochrane Database of Systematic Reviews
Abstract 
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Background
Autism spectrum disorders (ASDs) are characterised by impairments in communication and reciprocal social
interaction. These impairments can impact on relationships with family members, augment stress and frustration, and
contribute to behaviours that can be described as challenging. Family members of individuals with ASD can experience
high rates of carer stress and burden, and poor parental e icacy. While there is evidence to suggest that individuals with
ASD and family members derive benefit from psychological interventions designed to reduce stress and mental health
morbidity, and enhance coping, most studies to date have targeted the needs of either individuals with ASD, or family
members. We wanted to examine whether family (systemic) therapy, aimed at enhancing communication, relationships
or coping, is e ective for individuals with ASD and their wider family network.
Objectives
To evaluate the clinical e ectiveness and acceptability of family therapy as a treatment to enhance communication or
coping for individuals with ASD and their family members. If possible, we will also seek to establish the economic costs
associated with family therapy for this clinical population.
Search methods
On 16 January 2017 we searched CENTRAL, MEDLINE, Embase, 10 other databases and three trials registers. We also
handsearched reference lists of existing systematic reviews and contacted study authors in the field.
Selection criteria
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Randomised controlled trials (RCTs) and quasi‐RCTs investigating the e ectiveness of family therapy for young people
or adults with ASD or family members, or both, delivered via any modality and for an unspecified duration, compared
with either standard care, a wait‐list control, or an active intervention such as an alternative type of psychological
therapy.
Data collection and analysis
Two authors independently screened each title and abstract and all full‐text reports retrieved. To enhance rigour, 25%
of these were independently screened by a third author.
Main results
The search yielded 4809 records. Of these, we retrieved 37 full‐text reports for further scrutiny, which we subsequently
excluded as they did not meet the review inclusion criteria, and identified one study awaiting classification.
Authors' conclusions
Few studies have examined the e ectiveness of family therapy for ASD, and none of these are RCTs. Further research
studies employing methodologically robust trial designs are needed to establish whether family therapy interventions
are clinically beneficial for enhancing communication, strengthening relationships, augmenting coping and reducing
mental health morbidity for individuals with ASD and family members.
Plain language summary 
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Family therapy for autism spectrum disorders
Review question
What is the evidence that family therapy can help to improve communication, strengthen relationships, and enhance
coping, mental health and well‐being for people who have autism spectrum disorders (ASDs) or their family members,
or both?
Background
People with ASD o en experience di iculty with knowing how to communicate with others, and with developing and
maintaining friendships and relationships. They can also find it di icult to manage changes to their routine. People with
ASD tend to rely on family members, including parents and siblings, well into adulthood. Family members of people
with ASD sometimes experience stress, anxiety and depression.
Several research studies have investigated the benefits of talking therapies for individuals with ASD or for family
members. While study findings suggest that these therapies can improve communication and coping, and mental health
and well‐being, outcomes are usually reported for the person with ASD or family members, but not both.
Family therapy is designed to help people within the family make sense of di icult situations, and help them work
together to develop new ways of thinking about and managing these di iculties. It is important to find out if family
therapy can be helpful for people with ASD and their relatives given that the core symptoms of ASD, and additional
di iculties people can experience, o en impact on the family unit.
We searched for all the available evidence, published or unpublished, up until 16 January 2017, which examined family
therapy for ASD.
Study characteristics
While there have been a few studies investigating the benefits of family therapy interventions for ASD, none have
compared family therapy with either no treatment, a group of people waiting to start treatment, or another type of
psychological therapy. There is one study awaiting classification.
Quality of the evidence
There is limited high‐quality evidence available about whether family therapy is helpful for people with ASD or their
family members. More research studies are needed to evaluate the e ectiveness of family‐focused interventions to
enhance communication, reduce stress and improve coping.
Authors' conclusions 
Implications for practice
In spite of uncertainty about e ects, it may be that family therapy is deemed clinically appropriate, either in conjunction
with other prescribed treatments or as a stand‐alone intervention. Decisions to use family therapy should be made in
consultation with suitably qualified multidisciplinary professionals. Also, the use of family or systemic therapies should
be informed by best practice guidance for clinical work with this population (NICE 2012).
Implications for research
There are several implications for research. Building on the literature to date, there is a need for further intervention
studies that employ methodologically rigorous trial designs (i.e. RCTs). This may include studies that examine the
clinical utility and e ectiveness of psychoeducation for family members, couples therapy to strengthen relationships
and coping when one parent has ASD, and family or systemic therapy for parents, siblings, grandparents and children of
people with ASD, and dyads (e.g. members of two generations and young people or adults with ASD and members of
the immediate and extended family). Whether particular systemic approaches glean more favourable outcomes is yet to
be established, but this warrants further investigation. Similarly, consideration of treatment mediators and moderators
would prove beneficial. As a secondary objective, intervention studies should undertake process evaluations to
establish satisfaction and acceptability of these interventions for family members.
Background 
Description of the condition
Autism spectrum disorders (ASDs) are a cluster of childhood‐onset, neurodevelopmental conditions characterised by
qualitative impairments in communication, reciprocal social interaction, and restricted and repetitive interests and
behaviours (WHO 1992). There is substantial heterogeneity in the ASD symptom profile and clinical presentation; hence,
diagnosis is o en not made until late adolescence or adulthood (NICE 2012). Once thought to be fairly rare, current
prevalence estimates indicate that ASD is relatively common, a ecting at least 1% of the population (Brugha 2011).
The degree of impairment resulting from core ASD characteristics varies widely. Educational attainments are o en
poorer for younger people with ASD in comparison to typically developing peers (Levy 2011). Similarly, the adult ASD
population experiences significant di iculty with gaining and sustaining meaningful employment (Howlin 2013;
Mavranezouli 2014). A lack of peer and intimate relationships are frequently the norm (White 2009a), leading to
diminished social opportunities beyond those that stem from the family network, social isolation and loneliness. Daily
living and self‐su iciency skills can also be impeded, and individuals with ASD o en depend on ongoing support from
family members well into adulthood (Gray 2014; Magiati 2014).
ASDs are commonly associated with learning disability and high rates of psychiatric comorbidity (Hofvander 2009; Joshi
2013; Simono  2008), including anxiety disorders (Van Steensel 2011; White 2009b), depression (Ghaziuddin 2002),
attention deficit hyperactivity disorder traits (Taylor 2013), and more general "emotional and behavioural problems"
(Maskey 2013). Comorbidities further compound di iculties across multiple domains of functioning and exacerbate
reliance on family members as well as carer stress and burden (Cadman 2012).
The experiences and needs of family members of individuals with ASD have garnered increasing attention in recent
years. Findings from epidemiological and genetic studies indicate that ASD is a highly heritable condition (Hallmayer
2011; Lichtenstein 2010; Lundström 2010). Also, studies have found that parents of people with ASD can present with
higher levels of stress, distress, fatigue, anxiety, and depression symptoms than those reported for parents of typically
developing or other clinical populations (Cadman 2012; Firth 2013; Giallo 2013; Hoefman 2014). Additionally, research
findings suggest that carers can experience concerns about their parental e icacy and coping (Karst 2012), and that
marital satisfaction can be a ected (Hartley 2011). There has been some, albeit limited, research about siblings of
individuals with ASD. Tentative study findings suggest that some siblings may experience slightly elevated levels of
"behavioural problems" compared to non‐clinical populations (Hastings 2014), or features of anxiety (Shivers 2013).
Sibling adjustment and relationships may be a ected by the severity of ASD and associated symptoms (Petalas 2012;
Rivers 2003). Siblings may also be expected to take on more household duties (e.g. chores), or more responsibility (e.g.
informal caregiving) compared to the individual with ASD, although this is not a consistent finding across studies
(Meirsschaut 2011).
Description of the intervention
Family therapy can be defined as a formal, psychotherapeutic intervention, which seeks to understand and enhance
relationships, communication, and functioning between members of a family (Dallos 2010). While there are several
types of family therapy, they are predominantly underpinned by systemic theories and share central tenets (Hayes
1991). First, it is proposed that various problems, such as mental health functioning or the development and
maintenance of interpersonal relationships, are contextually bound (that is, they are likely to be predisposed and
perpetuated by the context and system(s) within which they occur, rather than solely being attributed to the individual
themselves) (Dallos 2010). Second, it is suggested that societal and cultural norms, values and expectations influence
and shape familial beliefs and behaviours both collectively (that is, the intergenerational family unit) and individually,
and that problems are best understood and addressed in terms of these influences. Third, it is hypothesised that the
family unit and the relationships between family members are dynamic (that is, that the reactions and responses of one
person a ect those of others in the system, in a bi‐directional fashion, linearly and longitudinally). Fourth, families are
said to develop ways of coping with periods of change and transition (e.g. births, marriages and bereavements), and
illness or adversity, in order to maintain stability as a unit (Goldenberg 2012). O en these patterns of coping are
adaptive and shared between all family members; yet, on occasion, individuals (within the family) may adopt distinct
coping styles leading to communication and relationship di iculties. Finally, it is considered that there are
commonalities in the ways that family members use language and narratives to converse and make sense of their own
and others’ experiences but also subtle di erences, which, in turn, may lead to or exacerbate ambiguity,
misinterpretation or disagreements.
Family therapists use a range of interventions (Dallos 2010), including psychoeducation; development of genograms to
map out cultural, resilience or other familial patterns (Butler 2008); narrative techniques (e.g. to explore language,
meanings and attributions) (Carr 1998); and the use of particular questioning styles (e.g. circular and reflexive questions
to enhance the breadth and depth of discussion) (Hayes 1991). In clinical practice, individuals presenting for family
therapy may be part of the same family or part of the wider friendship group. Individuals are encouraged to decide for
themselves who can and will engage in treatment, and the configuration of those attending may vary from session to
session. The duration of therapy can be several weeks to several months. Choices about the number of sessions to o er
are largely dependent on the service model and constraints, familial presenting needs and the therapist’s theoretical
stance.
How the intervention might work
Family therapy for ASD can be hypothesised to work in several ways (Goepfert 2015; Helps 2016; Ramisch 2013;
Solomon 2012). Individuals with ASD and family members can be supported to understand and make sense of the
diagnosis (e.g. through the use of psychoeducation). Discussion can be facilitated about preferences for using di erent
terminology to describe the core symptoms (e.g. autism spectrum ‘disorder’ or autism spectrum ‘condition’) and the
narratives and meanings that arise from this for individuals and the family unit collectively. The impact of core
characteristics (e.g. engagement in routines or impairments in socioemotional reciprocity such as a lack of empathy)
can be explored with a view to reducing feelings of frustration or annoyance. Interventions can encourage discussion
about broad factors and familial patterns or responses that may contribute to di iculties with communication and
relationships or challenging behaviour, and support the identification of strategies to promote cohesion within the
system. Family therapy can also encourage open dialogue between carers (e.g. about potential guilt or feelings of stress
or worry), and, in turn, strategies can be developed to enhance marital relationships, resilience and coping, and positive
parental mental health. Family therapy also provides a supportive therapeutic space for siblings to explore their
concerns or unanswered questions (e.g. about heredity factors or their current and potential prospective role as a
carer).
Why it is important to do this review
ASDs are common, lifelong disorders characterised by overt and subtle qualitative impairments in communication,
social interaction and relatedness, and preferences for engaging in restricted interests and repetitive behaviours (WHO
1992). Di iculties with tolerating uncertainty, ambiguity, and change within and beyond the immediate environment
are additional hallmark characteristics (APA 2013). Core ASD symptoms can impact significantly on daily social and
occupational functioning during childhood and adulthood. Individuals with ASD may find it di icult to initiate and
sustain interactions with others despite the desire for relationships (and increased social opportunities). Also,
symptoms of ASD typically impact others in the family (Hoefman 2014). Parents (carers) and siblings o en must
accommodate restricted interests and adherence to seemingly non‐functional routines. Inherent di iculties with
communication and interaction can adversely a ect relationships with, and between, family members. The need to
provide intensive and ongoing support to individuals with ASD can incur stress, anxiety and depression in carers, as well
as poor perceived parental e icacy and coping (Karst 2012).
There is no cure for ASD per se, and the heterogeneity of the disorder negates the use of monotherapy. Instead, the
more parsimonious approach is to develop combinations of interventions that 1) reduce or ameliorate the e ect and
impact of core ASD symptoms, and 2) support individuals and others around them to enhance their repertoire of skills
(Smith 2014; Woodman 2015). Further, interventions are needed across the lifespan to address the needs of children as
well as adults with ASD. There is promising evidence for the use of psychological interventions for individuals with ASD,
such as behavioural and cognitive‐behavioural (Lang 2010; Spain 2015a; Sukhodolsky 2013), social cognition (Fletcher‐
Watson 2014), and skills‐based interventions (Reichow 2013; Spain 2015b), but a limitation to these approaches is that
they do not explicitly address relationship and communication issues between family members, nor do they seek to
enhance familial coping strategies or resilience factors. Similarly, a recent review has highlighted the potential
e ectiveness of parent training for ASD (Oono 2013), but this approach encourages parents to take on a more facilitative
role, rather than specifically targeting their (potential) concurrent needs and the bi‐directional relationship between
individuals. Conversely, family therapy is a more inclusive intervention and has been found to be e ective for di erent
clinical populations (Carr 2009). Whether the structure or content of family therapy for individuals with ASD requires
adaptation (as is the case for other psychological therapies), for example to accommodate the impact of inherent
impairments, is not wholly clear. Undertaking a systematic review of the empirical data is important in order to:
1. ascertain the potential e ectiveness and acceptability of formal family therapy work for individuals with ASD;
2. establish whether there are integral features of these approaches that are associated with improved outcomes; and
3. consider how best interventions can be tailored to the specific lifelong needs of this clinical population and their
family members.
Objectives 
To evaluate the clinical e ectiveness and acceptability of family therapy as a treatment to enhance communication or
coping for individuals with ASD and their family members. If possible, we will also seek to establish the economic costs
associated with family therapy for this clinical population.
Methods 
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) and quasi‐RCTs (in which participants were allocated by alternate allocation, for
example according to days of the week). We excluded cross‐over trials and studies employing non‐RCT designs (such as
case studies or case series), due to the methodological limitations these can incur.
Types of participants
Families that have at least one person — child or adolescent (aged 17 years and under) or adult (aged 18 years and over)
— diagnosed with an ASD.
We defined ASD according to clinical criteria of either the International Classification of Diseases (WHO 1992), or the
Diagnostic and Statistical Manual of Mental Disorders (APA 2013), and ideally (but not necessarily) diagnosed using
standardised methods of assessment (e.g. the Autism Diagnostic Interview ‐ Revised (Lord 1994), or the Autism
Diagnostic Observation Schedule (Lord 2000)).
We defined family members as individuals from multi‐generations (parents, grandparents, siblings, children, or
spouses), either biologically related to the individual with ASD, or related through marriage or cohabitation. We also
included non‐professional carers (e.g. individuals providing foster or respite care) and significant others such as friends.
We included studies that described interventions delivered to participants residing in the same dwelling, or
interventions o ered to family members living separately.
We included studies in which participants had a comorbidity or were receiving other treatments concurrently to the
family therapy, although the intention was to clarify this level of detail from reports or by contacting trial authors.
Types of interventions
Family therapy
We included family therapy interventions delivered by at least one suitably qualified clinician, derived from systemic
theories, and specifically focusing on understanding, enhancing and improving aspects of relationships between
individuals with ASD and at least one family member; or between two or more members of the family of an individual
with ASD (e.g. parents, or parents and siblings). We included the following modalities of family therapy: systemic
therapy; structural family therapy; strategic family therapy; Milan approaches; solution‐focused therapy; narrative
therapy; and behavioural family therapy. The intervention had to have been o ered either face‐to‐face or via web‐based
real‐time sessions. We excluded studies that described pure bibliotherapy, psychoeducation or parent training
techniques. There was no stipulation regarding the number or duration of sessions delivered.
Control condition
We included four main types of comparator interventions.
1. No treatment.
2. Provision of standard clinical care (i.e. treatment as usual).
3. A wait‐list control (e.g. a delayed‐start intervention).
4. An active comparator (e.g. an alternative psychological intervention such as applied behavioural analysis or
cognitive behavioural therapy).
Types of outcome measures
We identified primary and secondary outcomes for individuals with ASD and family members. We included outcome
measures that generated either dichotomous or continuous data. To be eligible for inclusion, outcome measures
needed to be standardised and validated. While measures may not necessarily have been specifically validated for use
with the ASDs population, many intervention studies that include participants with ASD utilise measures (e.g. self‐
report questionnaires) that have been validated in non‐ASD samples (Lang 2010; Reichow 2013; Spain 2015a; Spain
2015b). The intention was to describe the psychometric properties of outcome measures, when possible, and highlight
whether there are indicative, normative thresholds (that is, cut‐o  scores) for ASD samples.
Outcome measures could have been completed by individuals with ASD, family members, or via objective (clinician‐
administered) instruments. Outcome measures could have been completed at di erent time points, including
postintervention or at follow‐up, or relating to short‐term changes (such as attributions about coping or satisfaction
with the intervention), and longer‐term outcomes (such as direct and indirect costs).
Primary outcomes
1. Quality or quantity of social interaction and communication (e.g. Social Responsiveness Scale by Constantino 2003;
Autism Diagnostic Observation Schedule by Lord 2000).
2. Mental health morbidity, including stress, anxiety or depression (e.g. Hospital Anxiety and Depression Scale by
Zigmond 1983).
3. Quality of life (e.g. EQ‐5D by Szenda 2007), including quality of relationships with family members (e.g. Family
Questionnaire by Wiedemann 2002).
4. Adverse e ects or events (e.g. increased mental health morbidities, as measured by the Hospital Anxiety and
Depression Scale (Zigmond 1983); or an increase in challenging behaviour).
Secondary outcomes
1. Confidence in, or attributions about, coping (e.g. Attributional Style Questionnaire by Seligman 1984).
2. Satisfaction with treatment (e.g. Client Satisfaction Questionnaire by Attkisson 1982).
3. Dropout from treatment.
4. Health economic outcomes, including direct costs (e.g. treatment costs) and indirect costs (e.g. use of clinical
services or work absence due to stress).
Search methods for identification of studies
We used a search strategy that combined two concepts: the condition (ASD) AND intervention (family therapy). We did
not limit the search by language, date, or publication status.
Electronic searches
We searched the following electronic databases and trial registers between 22 October and 4 November 2015 and again
in January 2017:
1. Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 11) in the Cochrane Library, which includes the
Cochrane Developmental, Psychosocial and Learning Problems Specialised Register (searched 18 January 2017);
2. MEDLINE Ovid (1946 to December Week 1 2016);
3. MEDLINE Ovid Epub Ahead of Print (16 January 2017);
4. MEDLINE Ovid In‐Process & Other Non‐Indexed Citations (16 January 2017);
5. Embase Ovid (1974 to 2017 Week 03);
6. CINAHL Plus EBSCOhost (Cumulative Index to Nursing and Allied Health Literature; 1937 to 17 January 2017);
7. Cochrane Database of Systematic Reviews (CDSR; 2017, Issue 1) part of the Cochrane Library (searched 18 January
2017);
8. Database of Abstracts of Reviews of E ects (DARE; 2015, Issue 2) part of the Cochrane Library (searched 18 January
2017);
9. ERIC EBSCOhost (Education Resources Information Center; 1966 to 17 January 2017);
10. PsycINFO Ovid (1967 to January Week 2 2017);
11. Sociological Abstracts ProQuest (1952 to 18 January 2017);
12. Dissertation Abstracts International ProQuest (1743 to 16 January 2017);
13. AutismData (autism.org.uk/autismdata; searched 18 January 2017);
14. UK Clinical Trials Gateway (UKCTG; ukctg.nihr.ac.uk; searched 18 January 2017); replaces UK Clinical Research
Network Study Portfolio.
15. ClinicalTrials.gov (clinicaltrials.gov; searched 18 January 2017);
16. World Health Organisation International Clinical Trials Registry Platform (WHO ICTRP;
apps.who.int/trialsearch/default.asp; searched 18 January 2017).
The exact strategy for each database is reported in Appendix 1. See Appendix 2 for a detailed summary of the searches
to date.
Searching other resources
We also undertook additional searches as follows: 1) we handsearched the reference lists of 10 review papers (Banda
2015; Cridland 2014; Dababnah 2016; Da Paz 2017; Gingerich 2013; Goepfert 2015; Karst 2012; Kaslow 2012; Ramisch
2013; Wainer 2016); and 2) we contacted a number of clinicians, including researchers who have undertaken studies in
the field, to ask if they knew of any studies not already identified by the searches.
Data collection and analysis
Selection of studies
Selection of studies involved several steps. We initially imported all citations retrieved from the searches into EndNote
(EndNote X7). A er removing duplicates, DS and JS independently screened the list of titles and abstracts for relevance.
Next, DS and JS inspected full reports of studies that appeared relevant or for which more information was needed.
They then independently assessed each text for eligibility based on the inclusion criteria outlined above (Criteria for
considering studies for this review). To enhance reliability and rigour, EP independently reviewed a random 25% of the
total sample of all titles and abstracts obtained, and a random 25% of all full‐text reports retrieved. There were no
disputes about the screening and inspection of reports. We recorded our decisions in a study flow diagram (Moher
2009).
Data extraction and management
Open in table viewer
No studies met the inclusion criteria for this review (Criteria for considering studies for this review).
Please see the protocol (Spain 2015c) and Table 1 for more information on methods archived for use in future updates of
this review.
Table 1. Unused methods sections
Unused
methods
Description of methods
Data
extraction
and
management
The data extraction form will include subheadings relating to the following areas.
1. Study methods (including methods of randomisation, allocation concealment, and blinding of research
personnel or participants).
2. Ethical approval (provision of informed consent or assent).
3. Referral route (method through which individuals are referred or present for family therapy).
4. Participant demographics and clinical diagnoses (including ASD and comorbid diagnoses).
5. Instruments used to diagnose ASD (including clinician‐administered assessments with either
participants or informants).
6. Active and comparator interventions (modality, content and duration of the active and comparator
interventions).
7. Outcome measurements (for individuals with ASD and their family members; and health outcome data,
if cited).
8. Results (including descriptive and inferential statistical data, as well as study results).
9. Adverse events (e.g. whether there has been an increase in mental health morbidities).
10. Treatment fidelity (e.g. whether a manualised treatment approach was used, if treatment sessions
were independently reviewed for adherence to the theoretical model, and the frequency and nature of
clinical supervision for trial therapists).
We will attempt to separate the outcomes and results between sites for any multi‐centre studies. In the
event that data described appear ambiguous for any of the reports, we will contact the authors for
clarification. If we are unable to liaise with report authors, we will document this within the review, and the
review team will discuss the discrepancies.
For any non‐English language studies, we will endeavour to arrange for report translation.
Assessment
of risk of bias
in included
studies
DS and JS will independently assess the risk of bias of all included studies across seven domains: random
sequence generation; allocation concealment; blinding of participants and trial sta ; blinding of outcome
assessments; incomplete outcome data; selective outcome reporting; and any other potential sources of
bias. For each included study, we will assign each of these domains one of three ratings: high risk of bias,
low risk of bias, or unclear risk of bias. We have detailed criteria for rating various domains of bias below,
with examples drawn from Chapter 8.5 of the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011a).
Random sequence generation
1. High risk of bias: a non‐random method is used to generate the sequence such as allocation by
alternate days or geographical location of entry to the trial.
2. Low risk of bias: random methods (e.g. random number table or computer random number generator)
are used to generate the sequence to produce comparable groups.
3. Unclear risk of bias: no or insu icient information is provided on the methods used to generate the
sequence to permit a judgement of high or low risk of bias.
Allocation concealment
1. High risk of bias: participants and researchers may have been able to foresee assignment to
intervention groups due to insu icient measures used to conceal allocation (such as open random
allocation schedule, unsealed or non‐opaque envelopes).
2. Low risk of bias: adequate methods are used to conceal the allocation (e.g. opaque envelope
procedure, central allocation or by independent personnel outside of the research team), so that
participants and researchers are unable to foresee or influence the assignment of intervention groups.
3. Unclear risk of bias: no or insu icient detail is provided on methods used to conceal the allocation
sequence to permit a judgement of high or low risk of bias.
Blinding of participants and research personnel
1. High risk of bias: neither participants nor research personnel are blinded to the treatment group
allocation or study hypotheses, and outcomes are likely to be influenced by such lack of blinding; or
blinding is attempted and subsequently broken; or some participants and personnel are blinded while
others are not blinded, which may introduce bias.
2. Low risk of bias: e ective measures (e.g. placebo or sham therapy sessions) are used to blind study
participants and research personnel from knowing intervention group allocation and study
hypotheses; or when blinding is not possible, study authors are able to justify that the outcome is
unlikely to be influenced by the lack of blinding.
3. Unclear risk of bias: either the study did not address this outcome or insu icient details are provided
on methods of blinding to permit a judgement of low or high risk of bias.
Blinding of outcome assessment
1. High risk of bias: outcome assessors are not blinded to treatment allocation of the study participants
and the study hypothesis, and the outcomes are likely to be influenced by the lack of blinding.
2. Low risk of bias: objective measures (such as biomedical measures of cortisol levels) that are unlikely to
be influenced by the lack of blinding outcome assessors are used; participants are unaware of which
intervention they have been allocated to; or participants' knowledge of which intervention they are
receiving does not mediate their response to subjective outcome measures.
3. Unclear risk of bias: there is a lack of detail on methods of blinding to permit a judgement of high or
low risk of bias.
Incomplete outcome data
1. High risk of bias: reasons for missing data are likely to be related to the true outcome; missing data are
not balanced across groups; or inappropriate methods are used to impute missing data.
2. Low risk of bias: no incomplete outcome data for each main outcome; reasons for missing data are
unlikely to be related to true outcome; missing data are balanced across groups; or appropriate
methods have been used to impute the data.
3. Unclear risk of bias: either the study did not address this outcome, or there is insu icient detail as
regards to the amount, nature, and handling of incomplete outcome data to permit a judgement of low
or high risk of bias.
Selective reporting
1. High risk of bias: not all prespecified outcomes are reported; or outcomes are reported using methods
not prespecified and for only a subgroup of the sample; or outcomes are reported that were not
prespecified; or outcomes are reported incompletely and cannot be included in a meta‐analysis.
2. Low risk of bias: all outcomes are reported as prespecified in published protocol, or the protocol is not
available but there is convincing text that suggests that all prespecified outcomes have been reported.
3. Unclear risk of bias: there is insu icient information (e.g. no protocol available) to permit a judgement
of high or low risk of bias.
Other sources of bias
1. High risk of bias: the study raises other important concerns, such as bias relating to the study design or
claims of fraudulence, or other sources of bias that are not covered by the above domains.
2. Low risk of bias: there is no evidence to suggest there are any other important concerns about bias not
addressed in the domains stated above.
3. Unclear risk of bias: there may be an additional risk of bias, but there is insu icient information to fully
assess this risk, or it is unclear that the risk would introduce bias in the study results.
We will obtain a third opinion from EP, MF or FH should there be disagreement about the 'Risk of bias'
assessment or a lack of consensus about any of the individual domains per study or in terms of the overall
appraisal of the trial. We will also attempt to contact report authors to provide clarification about aspects of
the trial, as needed.
'Summary of
findings'
tables
We will import data from Review Manager (Review Manager 2014), into GRADEprofiler (GRADEpro GDT), and
use this so ware to create 'Summary of findings' tables. These tables will provide outcome‐specific
information concerning the overall quality of the body of evidence from the studies included in the
comparison, the magnitude of e ect of the interventions examined, and the sum of available data on
outcomes rated as relevant to patient care and decision making.
We will employ the GRADE approach to assess the quality of evidence (Schünemann 2011), using the
following ratings: high quality (RCTs or quasi‐RCTs with a very low risk of bias), moderate quality (RCTs or
quasi‐RCTs with some evidence of risk of bias such as inadequate allocation concealment), low and very
low quality (RCTs or quasi‐RCTs that have significant threats to internal study validity such as failure to
adequately randomise participants, lack of blinding of outcome assessors, or selective outcome reporting)
(Schünemann 2011, Table 12.2.a).
We will include the following outcomes in the 'Summary of findings' tables.
1. Quality or quantity of social interaction or communication.
2. Mental health morbidity, including stress, anxiety, or depression.
3. Quality of life.
4. Confidence in or attributions about coping.
5. Adverse e ects or events.
Measures of
treatment
e ect
Dichotomous data
For dichotomous outcomes, such as the presence or absence of challenging behaviour(s), we will use the
Mantel‐Haenszel method for computing the pooled risk ratio (RR) (Mantel 1959). We will use the RR in meta‐
analyses, rather than the odds ratio (OR), because the OR can be susceptible to misinterpretation, which
can lead to overestimation of the benefits and harms of the intervention (Deeks 2011, Section 9.4.4.4). We
will report the RR with 95% CIs.
Continuous data
When di erent measures are used, we will calculate the standardised mean di erence and 95% CI. We will
calculate the mean di erence and 95% CI when all outcomes are measured using the same scale in the
same way.
Unit of
analysis
issues
Cluster trials
In cluster trials, the independence of individuals cannot be assumed (Higgins 2011b). As we are examining
the e ectiveness of an intervention for both individuals and family members, we may identify cluster‐
randomised trials.
If clustering has been incorporated into the analyses of primary studies, we plan to present these data as if
from a non‐cluster‐randomised study, but adjust for the clustering e ect. We will contact study authors for
more information if needed. If we identify cluster trials that have been analysed using incorrect statistical
methods (i.e. not taking the clustering into account), we will contact study authors to request individual
participant data so that we may calculate an estimate of the intracluster correlation coe icient (ICC). If we
are unable to obtain this information, we will adjust sample sizes using an estimate of the ICC from the trial
or from a trial of a similar population, with advice from a statistician, and use this to re‐analyse the data. In
the event that we are unable to adjust for incorrect statistical methods used by the cluster trials, and
therefore cannot estimate the ICC with any a degree of confidence, we will exclude the trial (Higgins 2011b).
We will investigate the robustness of our results by conducting sensitivity analyses, for example, to explore
the impact of di erent types of cluster‐randomisation units (such as families, health practitioners) (Higgins
2011b). We will also compare the results with and without cluster trials that have not been analysed
correctly by the trialists (where the ICC is estimated from other trials for the adjustment of cluster e ect)
(see Sensitivity analysis).
Cross‐over trials
Due to the issue of carry‐over, that is, whereby the e ectiveness of a second intervention may be mediated
by the first intervention, we will exclude cross‐over trials.
Multiple comparisons
Where a trial involves more than two treatment (or comparator) arms, we will first assess which
intervention (or comparator) groups are relevant to our review. We will use data from the arms of the trial
that are relevant to the review objectives, but present all intervention groups in the 'Characteristics of
included studies' tables, providing a detailed description of why we have selected particular groups and
excluded others. In the event that studies have more than two intervention groups and a control group that
are relevant to the review, we will split the control group data proportionately to the other two groups.
Repeated measures
When a trial reports outcome data obtained at more than one time point, we will conduct analyses
separately for each time point (e.g. postintervention and at follow‐up, if follow‐up is specified by the
trialist).
Dealing with
missing data
We will consider the possible impact of missing data on the results of the review.
Data may be missing either because (1) they have been insu iciently or inadequately reported, or (2) due to
dropout or attrition. In the event of insu icient or inadequate reporting, we will first try to obtain any
missing data from the trial authors, including unreported data (e.g. group means and SDs), details of
dropouts, and interventions provided. We will describe the missing data in the 'Risk of bias' table.
In either case outlined above, and when we cannot obtain data, we will conduct analyses using ITT
principles. For dichotomous outcomes (those not deemed to be missing at random), we will impute the
outcomes for the missing participants using both the most optimistic (i.e. assuming participants with
missing data improve) and the most pessimistic (i.e. assuming participants with missing data deteriorate)
scenarios.
When data are missing for continuous outcomes (e.g. data pertaining to means or SD), we will attempt to
calculate them based on the standard errors, CIs, and t values, according to the rules described in the
Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011c). If this information is missing,
and we are unable to obtain it from trial authors, we will report it as missing data in the review.
We will also conduct a sensitivity analysis to compare the results from the ITT analysis with the imputation
and ‘available case’ analysis (see Sensitivity analysis). If these analyses yield similar results in terms of the
e ects of treatment, we will present the results of the available case analyses.
Assessment
of
heterogeneity
Within each comparison, we will first assess clinical heterogeneity (e.g. variability in active and comparator
interventions, participant characteristics, or outcome measures used) and methodological heterogeneity
(e.g. variability in study design, including di erences in the nature of the randomisation unit and the size of
cluster randomised; and risk of bias, which we will assess according to the criteria outlined in the Cochrane
Handbook for Systematic Reviews of Interventions (Deeks 2011)). If there is clinical or methodological
heterogeneity, we will extract and document all of these characteristics onto the data extraction form and
synthesise the results narratively. We will then assess statistical heterogeneity using the I² and Chi²
statistics, and by visually inspecting the forest plots. If we identify a substantial level of heterogeneity in
trials (e.g. the I² is more than 30% to 60%, the P value is less than 0.10 in the Chi² test for heterogeneity, or
there is a di erent direction of the e ects), we will conduct prespecified subgroup analyses (see Subgroup
analysis and investigation of heterogeneity).
Assessment
of reporting
biases
We will assess reporting biases, including (multiple) publication, selective reporting, outcome and language
biases (Sterne 2011, Table 10.1.a). First, we will try to locate protocols of included trials. If the protocol is
available, we will compare outcomes documented in the protocol and the published report. If the protocol
is not available, we will compare outcomes listed in the methods section of the trial report with the
reported results. In addition, we will create funnel plots to investigate the possibility of publication bias and
other small‐study e ects when there is a su icient number of trials (10 or more). While funnel plots may be
useful in investigating reporting biases, there is some concern that tests for funnel plot asymmetry have
limited power to detect small‐study e ects, particularly when there are fewer than 10 studies, or when all
studies are of a similar sample size (Sterne 2011). In the event that funnel plots are possible, we will produce
them and seek statistical advice in their interpretation.
Data
synthesis
We will conduct random‐e ects meta‐analyses to produce the average e ect size of the intervention across
trials. A random‐e ects model is considered more appropriate than a fixed‐e ect model because the
population and setting of trials are likely to be di erent, and therefore the e ects are also likely to be
di erent (Deeks 2011).
Open in figure viewer
Subgroup
analysis and
assessment
of
heterogeneity
Depending on the sample size and heterogeneity of study populations, we propose to undertake subgroup
analyses as follows:
1. children and adolescents (aged 17 years and under) versus adults (aged 18 years and above) with ASD;
and
2. individuals with ASD who have a concurrent learning disability (i.e. IQ below 70) versus individuals with
ASD and no learning disability.
To limit the risk of multiple comparisons, we will conduct subgroup analyses on primary outcomes only.
Sensitivity
analysis
We will undertake sensitivity analyses to evaluate the impact of excluding trials (or trial data) that are
judged to have a high risk of bias (e.g. in terms of the domains of random sequence generation, allocation
concealment, blinding, or outcome reporting). We will also undertake sensitivity analyses to assess the
potential impact of missing outcome data.
ASD: autism spectrum disorder; CI: confidence interval; GRADE: Grades of Recommendation, Assessment, Development and
Evaluation; ITT: intention‐to‐treat; IQ: intelligence quotient; RCTs: randomised controlled trials; SD: standard deviation.
Results 
Description of studies
Results of the search
Please see Figure 1 for a flow diagram of the selection process.
Figure 1
Study flow diagram.
Our searches yielded 4805 database records (Electronic searches), and four additional records from other sources
(Searching other resources). We removed 1536 duplicates and reviewed 3273 records for eligibility (Criteria for
considering studies for this review). Two review authors (DS, JS) independently screened all titles and abstracts. A third
author (EP) screened 800 titles and abstracts (25%) independently to enhance rigour. We excluded 3234 records, as
none of these pertained to RCTs of family therapy for people with ASD.
We retrieved a total of 37 full‐text reports for further evaluation. Thirty‐four reports were written in English, one was
written in Chinese (Chen 2006), one in Japanese (Abe 2014), and one in German (Goll‐Kopka 2009). None of these
described RCTs of family therapy and all were excluded (see Excluded studies). One excluded study, Wagner 2014, made
reference to another, potentially relevant study. We contacted the author on two occasions but no further information
was available at this time, therefore we classified this as awaiting classification (Spain 2017 [pers comm]).
Included studies
None of the reports retrieved met the inclusion criteria for this review (Criteria for considering studies for this review).
Excluded studies
We excluded 37 reports. We excluded 11 discussion papers or reviews (A leck 1982; Alonim 2004; Brockman 2016;
Coleman 2015; Heller 2015; Helps 2016; Johnson 2012; Lordi 1964; Pickard 2017; Smock Jordan 2016; Wagner 2014), one
observational report (Altiere 2009), one qualitative study (Coogle 2016), and 24 intervention studies that were not RCTs
of family therapy (Abe 2014; Aerts 2011; Allen 1980; Alquraini 2015; Bennett 1983; Bennett 1986; Casenhiser 2011; Chen
2006; Chou 1992; Clancy 1972; Davis 1991; George 1988; Drahota 2008; Estreicher 1982; Goll‐Kopka 2009; Keen 2010;
NCT01919970; Pillay 2010; Roux 2013; Shank 1991; Siller 2013; Solomon 2008; Wang 2008; Whittingham 2009).
See Characteristics of excluded studies tables.
Risk of bias in included studies
Given that no studies met the review inclusion criteria (Criteria for considering studies for this review), we were unable
to assess risk of bias.
E ects of interventions
It was not possible to establish intervention e ectiveness, given the absence of data.
Discussion 
Summary of main results
We sought to establish the clinical and cost e ectiveness of family therapy for individuals with ASD. Despite an extensive
search, no RCTs met the a priori review inclusion criteria (Criteria for considering studies for this review), implying a gap
in the literature. One study is awaiting classification as no further information is available at this time.
Overall completeness and applicability of evidence
We were unable to assess completeness and applicability of evidence as no studies were included in this review.
Quality of the evidence
We were unable to assess the quality of the evidence as no studies were included in this review.
Potential biases in the review process
We consider that our search was rigorous and comprehensive. We conducted searches in 13 databases, including
seeking unpublished studies such as those described in dissertations and the grey literature. We also handsearched the
reference lists of a number of systematic and literature reviews. Finally, we contacted a couple of study authors to
ascertain whether they were aware of trial data that may be eligible for inclusion in this review.
Agreements and disagreements with other studies or reviews
No other systematic reviews focusing on RCTs of family therapy or systemic therapy for ASD were retrieved by our
search. We identified (but excluded) a few non‐randomised intervention studies that incorporated elements of systemic
therapy for family members of individuals with ASD (e.g. George 1988; Goll‐Kopka 2009; Wagner 2014). Evidence from
these studies suggests that knowledge and understanding of the core disorder (i.e. ASD), and coping styles may be
improved postintervention, albeit that use of less rigorous study designs means that results should be interpreted with
a degree of caution.
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Characteristics of studies 
Characteristics of excluded studies [ordered by study ID]
Jump to: awaiting classification
Study Reason for exclusion
Abe 2014 This is a non‐RCT study examining the e ectiveness of a support group for family members of people with
developmental disabilities. This support group is not family therapy.
Aerts 2011 This is a non‐RCT study comprising a psychiatric family treatment for family members of individuals with
autism. The intervention was competency based and is not family therapy.
A leck 1982 This is a review paper synthesising information about parent training approaches for individuals with
developmental disabilities.
Allen 1980 This is a two‐arm study comprising a transdisciplinary, early intervention programme for young children
with, or known to be at risk of, developmental disabilities compared to a treatment‐as‐usual group. Neither
intervention is family therapy.
Alonim 2004 This is a discussion paper about an early‐intervention approach for young people with ASD.
Alquraini
2015
This is a non‐RCT study comprising a relationship‐focused intervention to alleviate stress in mothers of
people with ASD. The intervention is not family therapy per se.
Altiere 2009 This is a cross‐sectional study investigating family dynamics and coping in parents of individuals with ASD.
Bennett 1983 This is a two‐arm study comprising a family‐oriented treatment for parents of children with disabilities
(primarily cerebral palsy) compared to a wait‐list control. Neither arm is family therapy.
Bennett 1986 This is a two‐arm study comprising a family‐oriented treatment for parents of children with disabilities
(primarily cerebral palsy) compared to a wait‐list control. Neither arm is family therapy.
Brockman
2016
This is a discussion paper, which provides an overview of the use of family therapy techniques for people
with ASD and family members. No RCT primary data is outlined.
Casenhiser
2011
This is a two‐arm RCT comprising a social‐communication‐based intervention for young children with autism
compared to a community treatment group (treatment as usual). Neither arm is family therapy.
Chen 2006 This is a two‐arm study comprising individualised hospital care for individuals with autism compared to a
family intervention. Participants were not randomised to either arm.
Study Reason for exclusion
Chou 1992 This is a two‐arm study comprising a task‐focused intervention, which incorporated systemic techniques, for
individuals with developmental disabilities compared with a control group receiving treatment as usual.
Participants were not randomised to either intervention.
Clancy 1972 This is a description of a clinical programme of systemic and family‐focused techniques for individuals with
autism. This is not a research trial and patients were not randomised to the programme.
Coleman
2015
This is a discussion paper about psychoeducation for family members of individuals with ASD.
Coogle 2016 This is a qualitative study focusing on the experiences of family members following engagement in an early
intervention.
Davis 1991 This is a two‐arm RCT comprising a home‐based, family‐focused counselling scheme for Bangladeshi families
who had children with a range of developmental disabilities compared to treatment as usual. Neither arm is
family therapy.
Drahota 2008 This is a two‐arm RCT comprising a 'building confidence' CBT intervention for young people with ASD
compared with a wait‐list control. Neither arm is family therapy.
Estreicher
1982
This is a single‐arm study comprising family therapy techniques for families with individuals with
developmental disabilities. Participants were not randomised to the intervention.
George 1988 This is a single‐arm study comprising a therapeutic group based on systemic principles for grandparents and
extended family members of individuals with developmental delays. The intervention is not family therapy
albeit that it incorporates systemic techniques.
Goll‐Kopka
2009
This is a description of 'The Frankfurt Multi‐family Therapy Model' for families who have children with
developmental or global disabilities or disorders. This is a pilot study and patients were not randomised to
the programme.
Heller 2015 This is a discussion paper and literature review about interventions for adults as they age. No primary data
are provided, nor is the review specifically about family therapy in ASD.
Helps 2016 This is a discussion paper and narrative review about family therapy interventions for family members of
individuals with ASD.
Johnson
2012
This is a review of therapeutic work with couples who have a child with ASD.
Keen 2010 This is a two‐arm quasi‐RCT comprising a parent‐focused intervention o ered via home‐based sessions and
a workshop for parents of children with ASD compared to a self‐directed video intervention. Neither arm is
family therapy.
Lordi 1964 This is a discussion paper providing an overview of infantile autism, including family‐focused working.
NCT01919970 This registration form pertains to a two‐arm RCT comprising an exposure‐based CBT treatment,
incorporating parent input for young people with ASD, compared to treatment as usual. Neither arm is family
therapy.
Study Reason for exclusion
Pickard 2017 This is a review and discussion paper about family‐focused ways of working with individuals with ASD.
Pillay 2010 This is a single‐arm study comprising a parent‐focused intervention for parents who have children with ASD.
The intervention is not family therapy.
Roux 2013 This is a two‐arm RCT comprising a group Stepping Stones Triple P intervention for parents of children with a
range of intellectual disabilities compared to a wait‐list control. Neither arm is family therapy.
Shank 1991 This is a single‐arm study comprising a problem‐solving technique for parents of a child with a disability. The
intervention is not family therapy albeit that it incorporates systemic techniques.
Siller 2013 This is a two‐arm RCT comprising a focused playtime intervention for parents of children with ASD compared
with psychoeducation. Neither arm is family therapy.
Smock
Jordan 2016
This is a discussion paper about solution‐focused therapy techniques for family members of individuals with
ASD. Case vignettes (non‐RCT data) are provided.
Solomon
2008
This is a two‐arm RCT comprising a parent‐child interaction therapy for parents of children with ASD
compared with a wait‐list control. Neither arm is family therapy.
Wagner 2014 This is a discussion paper, which also makes reference to a single‐arm intervention about a multi‐systemic
therapy for families of individuals with ASD. Participants were not randomised to the intervention.
Wang 2008 This is a two‐arm RCT comprising a parent training intervention for parents of children with autism
compared with a wait‐list control. Neither arm is family therapy.
Whittingham
2009
This is a two‐arm RCT comprising the Stepping Stones Triple P positive parenting programme for parents of
children with ASD compared with a wait‐list control. Neither arm is family therapy.
ASD: autism spectrum disorder; CBT: cognitive behavioural therapy; RCT: randomised controlled trial.
Characteristics of studies awaiting assessment [ordered by study
ID]
Jump to: excluded studies
Spain 2017 [pers comm]
Methods From a study by Wagner 2014, we noted the following sentence: "Building on the results from our pilot work,
we obtained grant funding to conduct a small randomized clinical trial for youths with ASD and severe
behavioral problems (expected N = 30)" (p 326). We contacted the senior author in 2016 and 2017 in order to
clarify the status of the trial.
Participants Not known
Interventions Not known
See more details
Outcomes Not known
Notes We corresponded with the senior author in 2016 and 2017 but insu icient detail about the study was
available.
ASD: autism spectrum disorder.
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Appendices
Appendix 1. Search strategies
Cochrane Central Register of Controlled Trials (CENTRAL) in the
Cochrane Library
#1[mh "child development disorders, pervasive"]
#2[mh ^"Developmental Disabilities"]
#3pervasive development* disorder*
#4(pervasive near/3 child*)
#5(PDD or PDDs or PDD‐NOS or ASD or ASDs)
#6autis*
#7asperger*
#8kanner*
#9childhood near/1 schizophreni*
#10{or #1‐#9}
#11[mh "family therapy"]
#12[mh "group therapy"]
#13[mh "psychotherapy, group"]
#14[mh "couples therapy"]
#15[mh "marital therapy"]
#16(systemic* near/3 psychotherap*)
#17(systemic* near/3 psycho‐therap*)
#18(systemic* near/3 famil*)
#19(famil* near/3 (intervention* or therap* or treat* or program*)) 4
#20(famil* near/3 (psychotherap* or psychoeducation* or psycho next education* or psycho next therap*)) 3
#21((marriage or marital or couple*) near/3 therap*)
#22(famil* near/1 (involv* or integrat* or participat* or focus*))
#23(psychodynamic or psycho next dynamic)
#24(group* near/3 psychotherap*)
#25(group* near/3 psycho next therap*)
#26(systemic next therap*)
#27(solution next focus*)
#28(narrative near/3 therap*)
#29{or #11‐#28}
#30#10 and #29 in Trials
MEDLINE Ovid
1 exp child development disorders, pervasive/
2 Developmental Disabilities/
3 pervasive development$ disorder$.tw.
4 (pervasive adj3 child$).tw.
5 (PDD or PDDs or PDD‐NOS or ASD or ASDs).tw.
6 autis$.tw.
7 asperger$.tw.
8 kanner$.tw.
9 childhood schizophreni$.tw.
10 or/1‐9
11 family therapy/
12 group therapy/
13 psychotherapy, group/
14 couples therapy/
15 marital therapy/
16 (systemic$ adj3 psychotherap$).tw.
17 (systemic$ adj3 psycho‐therap$).tw.
18 (systemic$ adj3 famil$).tw.
19 (famil$ adj3 (intervention$ or therap$ or treat$ or program$)).tw.
20 (famil$ adj3 (psychotherap$ or psychoeducation$ or psycho‐education$ or psycho‐therap$)).tw.
21 ((marriage or marital or couple$) adj3 therap$).tw.
22 (famil$ adj1 (involv$ or integrat$ or participat$ or focus$)).tw.
23 (psychodynamic or psycho‐dynamic).tw.
24 (group$ adj3 psychotherap$).tw.
25 (group$ adj3 psycho‐therap$).tw.
26 systemic therap$.tw.
27 solution focus$.tw.
28 (narrative adj1 therap$).tw.
29 or/11‐28
30 10 and 29
MEDLINE Ovid Epub Ahead of Print
1 pervasive development$ disorder$.tw.
2 (pervasive adj3 child$).tw.
3 (PDD or PDDs or PDD‐NOS or ASD or ASDs).tw.
4 autis$.tw.
5 asperger$.tw.
6 kanner$.tw.
7 childhood schizophrenia.tw.
8 or/1‐7
9 (systemic$ adj3 psychotherap$).tw.
10 (systemic$ adj3 psycho‐therap$).tw.
11 (systemic$ adj3 famil$).tw.
12 (famil$ adj3 (intervention$ or therap$ or treat$ or program$)).tw.
13 (famil$ adj3 (psychotherap$ or psychoeducation$ or psycho‐education$ or psycho‐therap$)).tw.
14 (famil$ adj1 (involv$ or integrat$ or participat$ or focus$)).tw.
15 ((marriage or marital or couple$) adj3 therap$).tw.
16 (psychodynamic or psycho‐dynamic).tw.
17 (group$ adj3 psychotherap$).tw.
18 (group$ adj3 psycho therap$).tw.
19 systemic therap$.tw.
20 solution focus$.tw.
21 (narrative adj1 therap$).tw.
22 or/9‐21
23 8 and 22
MEDLINE Ovid In‐Process and Other Non‐Indexed Citations
1 pervasive development$ disorder$.tw.
2 (pervasive adj3 child$).tw.
3 (PDD or PDDs or PDD‐NOS or ASD or ASDs).tw.
4 autis$.tw.
5 asperger$.tw.
6 kanner$.tw.
7 childhood schizophrenia.tw.
8 or/1‐7
9 (systemic$ adj3 psychotherap$).tw.
10 (systemic$ adj3 psycho‐therap$).tw.
11 (systemic$ adj3 famil$).tw.
12 (famil$ adj3 (intervention$ or therap$ or treat$ or program$)).tw.
13 (famil$ adj3 (psychotherap$ or psychoeducation$ or psycho‐education$ or psycho‐therap$)).tw.
14 (famil$ adj1 (involv$ or integrat$ or participat$ or focus$)).tw.
15 ((marriage or marital or couple$) adj3 therap$).tw.
16 (psychodynamic or psycho‐dynamic).tw.
17 (group$ adj3 psychotherap$).tw.
18 (group$ adj3 psycho therap$).tw.
19 systemic therap$.tw.
20 solution focus$.tw.
21 (narrative adj1 therap$).tw.
22 or/9‐21
23 8 and 22
Embase OVID
1 exp autism/
2 pervasive development$ disorder$.tw.
3 (PDD or PDDs or ASD or ASDs).tw.
4 autis$.tw.
5 asperger$.tw.
6 kanner$.tw.
7 childhood schizophreni$.tw.
8 Rett$.tw.
9 (pervasive adj3 child$).tw.
10 or/1‐9
11 family therapy/
12 group therapy/
13 marital therapy/
14 (systemic$ adj3 psychotherap$).tw.
15 (systemic$ adj3 psycho‐therap$).tw.
16 (systemic$ adj3 famil$).tw.
17 (famil$ adj3 (intervention$ or therap$ or treat$ or program$)).tw.
18 (famil$ adj3 (psychotherap$ or psychoeducation$ or psycho‐education$ or psycho‐therap$)).tw.
19 ((marriage or marital or couple$) adj3 therap$).tw.
20 (famil$ adj1 (involv$ or integrat$ or participat$ or focus$)).tw.
21 (psychodynamic or psycho‐dynamic).tw.
22 (group$ adj3 psychotherap$).tw.
23 (group$ adj3 psycho‐therap$).tw.
24 systemic therap$.tw.
25 solution focus$.tw.
26 (narrative adj1 therap$).tw.
27 or/11‐26
28 10 and 27
CINAHLPlus EBSCOhost (Cumulative Index to Nursing and Allied Health
Literature)
S27 S9 AND S26
S26 S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR
S25
S25 (narrative N1 therap*)
S24 solution focus*
S23 systemic therap*
S22 (group* N3 (psychotherap* or psycho‐therap*) )
S21 (psychodynamic or psycho‐dynamic)
S20 (famil* N1 (involv* or integrat* or participat* or focus*))
S19 ((marriage or marital or couple*) N3 therap*)
S18 (famil* N3 (psychotherap* or psychoeducation* or psycho‐education*or psycho‐therap*))
S17 (famil* N3 (intervention* or therap* or treat* or program*))
S16 (systemic* N3 famil*)
S15 (systemic* N3 psycho‐therap*)
S14 (systemic* N3 psychotherap*)
S13 (MH "Couples Counseling")
S12 (MH "Psychotherapy, Group")
S11 (MH "Family Therapy")
S10 (MH "Family Systems Theory") OR (MH "Family Services")
S9 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8
S8 (MH "Developmental Disabilities")
S7 childhood schizophren*
S6 Kanner*
S5 Rett*
S4 Asperger*
S3 (autis* or ASD or ASDs)
S2 (pervasive development* disorder* or PDD or PDDs)
S1 (MH "Child Development Disorders, Pervasive+")
Cochrane Database of Systematic Reviews (CDSR) part of the Cochrane
Library
#1[mh "child development disorders, pervasive"]
#2[mh ^"Developmental Disabilities"]
#3"pervasive development* disorder*":ti,ab
#4(pervasive near/3 child*):ti,ab
#5autis* :ti,ab
#6asperger*:ti,ab
#7kanner*:ti,ab
#8{or #1‐#7}
#9[mh "family therapy"]
#10[mh "group therapy"]
#11[mh "psychotherapy, group"]
#12[mh "couples therapy"]
#13[mh "marital therapy"]
#14(systemic* near/3 psychotherap*):ti,ab
#15(systemic* near/3 psycho‐therap*):ti,ab
#16(systemic* near/3 famil*):ti,ab
#17(famil* near/3 (intervention* or therap* or treat* or program*)):ti,ab
#18(famil* near/3 (psychotherap* or psychoeducation* or psycho next education* or psycho next therap*)):ti,ab
#19((marriage or marital or couple*) near/3 therap*):ti,ab
#20(famil* near/1 (involv* or integrat* or participat* or focus*)):ti,ab
#21(psychodynamic or psycho next dynamic):ti,ab
#22(group* near/3 psychotherap*):ti,ab
#23(group* near/3 psycho next therap*):ti,ab
#24("systemic therap*"):ti,ab
#25("solution focus*"):ti,ab
#26(narrative near/1 therap*):ti,ab
#27{or #9‐#26}
#28#8 and #27
Database of Abstracts of Reviews of E ects (DARE) part of the Cochrane
Library
#1[mh "child development disorders, pervasive"]
#2[mh ^"Developmental Disabilities"]
#3"pervasive development* disorder*"
#4(pervasive near/3 child*)
#5autism or autistic
#6asperger*
#7kanner*:
#8{or #1‐#7}
#9[mh "family therapy"]
#10[mh "group therapy"]
#11[mh "psychotherapy, group"]
#12[mh "couples therapy"]
#13[mh "marital therapy"]
#14(systemic* near/3 psychotherap*)
#15(systemic* near/3 psycho‐therap*)
#16(systemic* near/3 famil*):
#17(famil* near/3 (intervention* or therap* or treat* or program*))
#18(famil* near/3 (psychotherap* or psychoeducation* or psycho next education* or psycho next therap*))
#19((marriage or marital or couple*) near/3 therap*)
#20(famil* near/1 (involv* or integrat* or participat* or focus*))
#21(psychodynamic or psycho next dynamic)
#22(group* near/3 psychotherap*)
#23(group* near/3 psycho next therap*)
#24("systemic therap*")
#25("solution focus*"):
#26(narrative near/1 therap*)
#27{or #9‐#26}
#28#8 and #27
ERIC EBSCOhost (Education Resources Information Center)
S27 S9 AND S26
S26 S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR
S25
S25 (narrative N1 therap*)
S24 "solution focus*"
S23 "systemic therap*"
S22 (group* N3 (psychotherap* or psycho‐therap*))
S21 (psychodynamic or psycho‐dynamic)
S20 TI(famil* N1 (involv* or integrat* or participat* or focus*)) OR AB(famil* N1 (involv* or integrat* or participat* or
focus*)
S19 TI ((marriage or marital or couple*) N3 therap*) OR AB((marriage or marital or couple*) N3 therap*) Search modes ‐
Boolean/Phrase
S18 TI(famil* N3 (psychotherap* or psychoeducation* or psycho‐education* or psycho‐therap*))OR AB(famil* N3
(psychotherap* or psychoeducation* or psycho‐education* or psycho‐therap*))
S17 TI(famil* N3 (intervention* or therap* or treat* or program*)) OR AB(famil* N3 (intervention* or therap* or treat* or
program*))
S16 (systemic* N3 famil*)
S15 (systemic* N3 psycho‐therap*)
S14 (systemic* N3 psycho‐therap*)
S13 (systemic* N3 psychotherap*)
S12 DE "Marriage Counseling"
S11 DE "Group Counseling" OR DE "Group Therapy"
S10 DE "Family Counseling" OR DE "Family Involvement" OR DE "Family Programs"
S9 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8
S8 childhood schizophren*
S7 Kanner*
S6 Rett*
S5 Asperger*
S4 (autis* or ASD or ASDs)
S3 (pervasive development* disorder* or PDD or PDDs)
S2 DE "Pervasive Developmental Disorders" OR DE "Asperger Syndrome" OR DE "Autism"
S1 DE "Developmental Disabilities"
PsycINFO (Ovid)
1 exp pervasive developmental disorders/
2 Developmental disabilities/
3 pervasive development$ disorder$.tw.
4 (pervasive adj3 child$).tw.
5 autis$.tw.
6 asperger$.tw.
7 (autis$ or ASD or ASDs).tw.
8 Rett$.tw.
9 Kanner$.tw.
10 (PDD or PDDs or PDD‐NOS).tw.
11 childhood schizophreni$.tw.
12 or/1‐11
13 exp family therapy/
14 family intervention/
15 group psychotherapy/
16 conjoint therapy/
17 couples therapy/
18 marriage counseling/
19 (systemic$ adj3 psychotherap$).tw.
20 (systemic$ adj3 psycho‐therap$).tw.
21 (systemic$ adj3 famil$).tw.
22 (famil$ adj3 (intervention$ or therap$ or treat$ or program$)).tw.
23 (famil$ adj3 (psychotherap$ or psychoeducation$ or psycho‐education$ or psycho‐therap$)).tw.
24 ((marriage or marital or couple$) adj3 therap$).tw.
25 (famil$ adj1 (involv$ or integrat$ or participat$ or focus$)).tw.
26 (psychodynamic or psycho‐dynamic).tw.
27 (group$ adj3 psychotherap$).tw.
28 (group$ adj3 psycho‐therap$).tw.
29 systemic therap$.tw.
30 solution focus$.tw.
31 (narrative adj1 therap$).tw.
32 or/13‐31
33 12 and 32
Sociological Abstracts ProQuest
SU.EXACT("Autism") OR autis* or asperger* or kanner* or Rett* or pervasive N3 disorder* or pervasive N3 child* OR PDD
or PDDs or PDD‐NOS or ASD or ASDs) AND ((famil* N/3 (intervention* or therap* or treat* or program*)) or (famil* N/3
(psychotherap* or psychoeducation* or "psycho education*" or "psycho therap*")) or (systemic* N/3 psychotherap*) or
(systemic* N/3 "psycho‐ therap*") or (famil* N/1 (involv* or integrat* or participat* or focus*)) OR (group* N/3
psychotherap*) or systemic therap* or (group* N/3 psychotherap*) or (group* N/3 ("psycho‐therap*" or
psychoeducation* or "psycho education*" or "psycho therap*")))
Dissertation Abstracts International ProQuest
(ab(child developmental disorders) OR ab((pervasive developmental disorders OR developmental disabilit$)) OR
ab((pervasive development$ disorder$ OR pervasive adj3 child$)) OR ab((PDD OR PDDs OR PDD‐NOS OR ASD OR ASDs
OR autis$)) OR ab((asperger$ OR kanner$)) OR ab(childhood schizophrenia)) AND (ab(family therapy) OR ab((group
therapy OR group psychotherapy)) OR ab((couples therapy OR marital therapy)) OR ab((systemic$ adj3 psychotherap$
OR systemic$ adj3 psycho‐therap$)) OR ab((systemic$ adj3 famil$ OR famil$ adj3 (intervention$ OR therap$ OR treat$
OR program$))) OR ab((famil$ adj3 (psychotherap$ OR psychoeducation$ OR psycho‐education$ OR psycho‐therap$)
OR (marriage OR marital OR couple$) adj3 therap$)) OR ab((famil$ adj1 (involv$ OR integrat$ OR participat$ OR focus$)
OR psychodynamic OR psycho‐dynamic)) OR ab((group$ adj3 psychotherap$ OR group$ adj3 psycho therap$)) OR
ab((systemic therap$ OR solution focus$)) OR ab(narrative adj1 therap))
AutismData
(autism.org.uk/autismdata)
Searched "family therapy" as keyword
Records were compared manually with EN library; 6 unique records added to Endnote
UK Clinical Research Network (UKCRN) Study Portfolio
(public.ukcrn.org.uk/search)
Searches:
Speciality : Mental health
Subtopic: Autism spectrum disoders
Research summary: family
Speciality : Mental health
Subtopic: Autism spectrum disoders
Research summary: systemic
Speciality : Mental health
Subtopic: Autism spectrum disoders
Research summary: psychotherapy
Speciality : Mental health
Subtopic: Autism spectrum disoders
Research summary: multisystemic
UK Clinical Trials Gateway (UKCTG)
(ukctg.nihr.ac.uk)
family therapy autis*
systemic autis*
multisystemic autis*
ClinicalTrials.gov
(clinicaltrials.gov/ct2/home)
autism | (family OR systemic OR group) AND (therapy) OR autism | (family OR systemic OR group) AND (psychotherapy)
World Health Organisation International Clinical Trials Registry
Platform (WHO ICTRP)
(apps.who.int/trialsearch/AdvSearch.aspx)
Basic search: Autism AND group OR autism AND family or autism AND parent OR autism AND systemic
Appendix 2. Record of searches
Database Search
date
Date
range/issue
Number
of
records
Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane
Library
23
October
2015
Issue 9 of 12,
September 2015
75
18
January
2017
Issue 11 of 12,
November 2016
15
MEDLINE Ovid 22
October
2015
1946 to October
Week 3 2015
559
17
January
2017
1946 to December
Week 1 2016
74
MEDLINE Ovid Epub Ahead of Print 17
January
2017
16 January 2017 15
MEDLINE Ovid In‐Process & Other Non‐Indexed Citations 17
January
2017
16 January 2017 39
Embase OVID 22
October
2015
1974 to 2015
Week 42
695
17
January
2017
1974 to 2017
Week 3
94
CINAHL Plus EBSCOhost (Cumulative Index to Nursing and Allied Health
Literature)
23
October
2015
1937 to current 402
17
January
2017
1937 to current 22
Cochrane Database of Systematic Reviews (CDSR) part of the Cochrane Library 23
October
2015
Issue 10 of 12,
October 2015
15
18
January
2017
Issue 1 of 12,
January 2015
6
Database of Abstracts of Reviews of E ects (DARE) part of the Cochrane Library 23
October
2015
Issue 2 of 4, April
2015
4
ERIC EBSCOhost (Education Resources Information Center) 23
October
2015
1966 to current 564
17
January
2017
1966 to current 32
PsycINFO OVID 22
October
2015
1967 to October
Week 3 2015
1417
17
January
2017
1967 to January
Week 2 2017
118
Sociological Abstracts ProQuest 23
October
2015
1952 to current 52
18
January
2017
1952 to current 4
Dissertation Abstracts International ProQuest 4
November
2015
1743 to current 176
16
January
2017
1743 to current 215
AutismData (autism.org.uk/autismdata) 23
October
2015
All years 6
18
January
2017
All years 4
UK Clinical Research Network Study Portfolio (UKCRN;
public.ukcrn.org.uk/search); replaced by UK Clinical Trials Gateway
23
October
2015
All years 1
UK Clinical Trials Gateway (UKCTG; ukctg.nihr.ac.uk); replaces UK Clinical
Research Network Study Portfolio
18
January
2017
All years 1
ClinicalTrials.gov (clinicaltrials.gov/ct2/home) 23
October
2015
All years 82
18
January
2017
All years 24
World Health Organisation International Clinical Trials Registry Platform (WHO
ICTRP; apps.who.int/trialsearch/AdvSearch.aspx)
23
October
2015
All years 91
18
January
2017
All years 3
Total records 4805
